Early test of new weapon against rheumatoid arthritis
NCT ID NCT07347860
Summary
This early study is testing the safety of a new drug called A-319 for people with active rheumatoid arthritis (RA) who haven't gotten enough relief from at least two other standard treatments. The drug works by guiding the body's own immune T-cells to find and destroy harmful B-cells thought to drive the disease. Researchers will enroll 12 participants to check for side effects and see how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wuhan Union Hospital
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.